Sun Pharmaceutical Industries Executes ₹20.56 Crore Block Trade on NSE

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

Sun Pharmaceutical Industries Ltd. completed a block trade worth ₹20.56 crores on NSE, involving approximately 125,250 shares at ₹1,641.20 per share. The transaction represents significant institutional activity in the pharmaceutical company's stock through the block trade mechanism.

powered bylight_fuzz_icon
30438897

*this image is generated using AI for illustrative purposes only.

Sun pharmaceutical Industries Ltd. executed a significant block trade on the National Stock Exchange (NSE), marking a notable institutional transaction in the pharmaceutical sector.

Transaction Details

The block trade involved substantial volume and value, demonstrating institutional interest in the pharmaceutical major's shares.

Parameter: Details
Total Transaction Value: ₹20.56 crores
Number of Shares: ~125,250 shares
Execution Price: ₹1,641.20 per share
Exchange: National Stock Exchange (NSE)

Block Trade Mechanism

Block trades represent large-volume transactions executed outside regular market hours or through special trading windows. These transactions allow institutional investors to trade substantial quantities without significantly impacting the stock's market price. The mechanism provides efficient execution for large orders while maintaining market stability.

Market Implications

The execution of this block trade indicates institutional activity in Sun Pharmaceutical Industries' shares. Such transactions typically involve institutional investors, mutual funds, or other large market participants seeking to adjust their portfolio positions. The specific price of ₹1,641.20 per share reflects the negotiated rate between the participating parties in this off-market transaction.

Historical Stock Returns for Sun Pharmaceutical

1 Day5 Days1 Month6 Months1 Year5 Years
-0.90%-0.97%-5.96%+2.95%+5.06%0.0%
Disclaimer: This article is AI-generated using data from LiveSquawk. ScanX is not liable for any inaccuracies.

More News on Sun Pharmaceutical

1 Year Returns:+5.06%